story of the week
Cabozantinib in Advanced Non–Clear Cell Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cabozantinib in Advanced Non-Clear-Cell Renal Cell Carcinoma: A Multicentre, Retrospective, Cohort Study
Lancet Oncol 2019 Feb 28;[EPub Ahead of Print], N Martínez Chanzá, W Xie, M Asim Bilen, H Dzimitrowicz, J Burkart, DM Geynisman, A Balakrishnan, IA Bowman, R Jain, W Stadler, Y Zakharia, V Narayan, B Beuselinck, RR McKay, A Tripathi, R Pachynski, AW Hahn, J Hsu, SA Shah, ET Lam, TL Rose, AE Mega, N Vogelzang, MR Harrison, A Mortazavi, ER Plimack, U Vaishampayan, H Hammers, S George, N Haas, N Agarwal, SK Pal, S Srinivas, BA Carneiro, DYC Heng, D Bosse, TK Choueiri, LC HarshmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.